XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance at Jan. 31, 2023 $ 150,264 $ 0 $ 561,547 $ (807) $ (410,476)
Beginning balance (in shares) at Jan. 31, 2023   45,432,029      
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock upon exercise of stock options 1,917   1,917    
Issuance of common stock upon exercise of stock options (in shares)   389,377      
Issuance of common stock in connection with employee stock purchase plan 847   847    
Issuance of common stock in connection with employee stock purchase plan (in shares)   74,113      
Vesting of restricted stock units (in shares)   259,980      
Stock-based compensation 9,480   9,480    
Net unrealized gains (losses) on investments 317     317  
Net loss (21,875)       (21,875)
Ending balance at Apr. 30, 2023 140,950 $ 0 573,791 (490) (432,351)
Ending balance (in shares) at Apr. 30, 2023   46,155,499      
Beginning balance at Jan. 31, 2024 $ 130,421 $ 0 621,024 56 (490,659)
Beginning balance (in shares) at Jan. 31, 2024 49,079,876 49,079,876      
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock upon exercise of stock options $ 3,294   3,294    
Issuance of common stock upon exercise of stock options (in shares)   406,055      
Issuance of common stock in connection with employee stock purchase plan 1,795   1,795    
Issuance of common stock in connection with employee stock purchase plan (in shares)   123,778      
Vesting of restricted stock units (in shares)   610,551      
Stock-based compensation 14,818   14,818    
Net unrealized gains (losses) on investments (271)     (271)  
Net loss (20,995)       (20,995)
Ending balance at Apr. 30, 2024 $ 129,062 $ 0 $ 640,931 $ (215) $ (511,654)
Ending balance (in shares) at Apr. 30, 2024 50,220,260 50,220,260